应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
01093 石药集团
未开盘 09-22 16:08:13
9.710
+0.105
+1.09%
最高
9.730
最低
9.400
成交量
8,295万
今开
9.535
昨收
9.605
日振幅
3.44%
总市值
1,119亿
流通市值
1,119亿
总股本
115.22亿
成交额
8.00亿
换手率
0.72%
流通股本
115.22亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
“药二代”密集走向台前，大多拥有海外名校背景，将如何接好“转型”这一棒？
红星资本局 · 09-22 20:16
“药二代”密集走向台前，大多拥有海外名校背景，将如何接好“转型”这一棒？
2026民营企业500强退步榜：永辉超市排名下降57名，宁波合盛集团下降56名，石药控股下降53名
新浪证券 · 09-22 19:39
2026民营企业500强退步榜：永辉超市排名下降57名，宁波合盛集团下降56名，石药控股下降53名
石药集团：贝莱德增持，好仓比例升至5.0%
港股披露 · 09-22 17:24
石药集团：贝莱德增持，好仓比例升至5.0%
石药集团：贝莱德减持，好仓比例降至4.85%
港股披露 · 09-21 17:42
石药集团：贝莱德减持，好仓比例降至4.85%
花旗：医药工业发展“十五五”规划利好创新药及医疗器械 首选石药集团(01093)等
智通财经 · 09-21 15:03
花旗：医药工业发展“十五五”规划利好创新药及医疗器械 首选石药集团(01093)等
港股开盘 | 恒指平开 医药股多数走强 信达生物(01801)涨近2%
智通财经网 · 09-21 09:42
港股开盘 | 恒指平开 医药股多数走强 信达生物(01801)涨近2%
石药集团：老牌仿创药企的资本与业务重构
蓝鲸财经 · 09-20 14:11
石药集团：老牌仿创药企的资本与业务重构
石药集团2026年上半年营收185.94亿元，经调整净利润61.64亿元
公告速递 · 09-17
石药集团2026年上半年营收185.94亿元，经调整净利润61.64亿元
石药集团(01093)SYH2069注射液治疗成人2型糖尿病II期试验在中国首个研究中心启动
公告速递 · 09-16
石药集团(01093)SYH2069注射液治疗成人2型糖尿病II期试验在中国首个研究中心启动
石药集团(01093.HK)：SYH2069注射液用于治疗成人2型糖尿病的II期临床试验在中国首个研究中心正式启动
智通财经 · 09-16
石药集团(01093.HK)：SYH2069注射液用于治疗成人2型糖尿病的II期临床试验在中国首个研究中心正式启动
【投融资动态】达石药业D+轮融资，投资方为维度资本、贵阳创投等
证券之星 · 09-15
【投融资动态】达石药业D+轮融资，投资方为维度资本、贵阳创投等
石药集团SYS 6010被纳入国家药监局突破性治疗品种清单
公告速递 · 09-15
石药集团SYS 6010被纳入国家药监局突破性治疗品种清单
智通港股早知道 | 国产创新药WCLC数据密集兑现 投行看好中国CRO/CDMO复苏明确
智通财经 · 09-15
智通港股早知道 | 国产创新药WCLC数据密集兑现 投行看好中国CRO/CDMO复苏明确
石药集团(01093.HK)：SYS 6010联合恩朗苏拜单抗用于治疗未经系统性治疗的驱动基因阴性晚期NSCLC的I / II期临床研究数据于2026年世界肺癌大会(WCLC)上以口头报告形式公布
智通财经 · 09-14
石药集团(01093.HK)：SYS 6010联合恩朗苏拜单抗用于治疗未经系统性治疗的驱动基因阴性晚期NSCLC的I / II期临床研究数据于2026年世界肺癌大会(WCLC)上以口头报告形式公布
港股异动 | 创新药概念股持续调整 海外利率预期反复 2026国谈收官进入结果等待期
智通财经 · 09-11
港股异动 | 创新药概念股持续调整 海外利率预期反复 2026国谈收官进入结果等待期
全球股市综述：市场快讯
投资观察 · 09-10
全球股市综述：市场快讯
大行评级丨里昂：重申石药“高确信跑赢大市”评级，股价急挫创造入市机会
中金财经 · 09-10
大行评级丨里昂：重申石药“高确信跑赢大市”评级，股价急挫创造入市机会
港股异动 | 石药集团(01093)跌超4% Lp(a)HORIZON研究受阻或对包括公司在内的参与者构成压力
智通财经 · 09-10
港股异动 | 石药集团(01093)跌超4% Lp(a)HORIZON研究受阻或对包括公司在内的参与者构成压力
里昂：重申石药集团(01093.HK)“高确信跑赢大市”评级 目标价19港元
智通财经 · 09-10
里昂：重申石药集团(01093.HK)“高确信跑赢大市”评级 目标价19港元
异动解读｜石药集团盘中下跌3.3%，医药板块整体承压延续调整
行情直击 · 09-10
异动解读｜石药集团盘中下跌3.3%，医药板块整体承压延续调整
加载更多
公司概况
公司名称：
石药集团
所属市场：
SEHK
上市日期：
--
主营业务：
石药集团有限公司是一家主要从事药品的生产及销售的公司。该公司主要从事成药业务、原料产品业务、功能食品及其他业务。该公司的产品主要涵盖神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢以及其他治疗领域。该公司的产品销往国内外市场。
发行价格：
--
{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":9.71,"timestamp":1790064493003,"preClose":9.605,"halted":0,"volume":82950370,"delay":0,"changeRate":0.01093180635085897,"floatShares":11522000000,"shares":11522000000,"eps":0.3977975370424115,"marketStatus":"未开盘","change":0.105,"latestTime":"09-22 16:08:13","open":9.535,"high":9.73,"low":9.4,"amount":799570195,"amplitude":0.034357,"askPrice":9.71,"askSize":234000,"bidPrice":9.705,"bidSize":180000,"shortable":3,"etf":0,"ttmEps":0.7615434644322255,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790127000000},"marketStatusCode":0,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":9.605,"dividendRate":0.029887,"openAndCloseTimeList":[[1790040600000,1790049600000],[1790053200000,1790064000000]],"volumeRatio":1.174292,"optionData":{"bulkOrders":[{"symbol":"CSP.HK","call":true,"expireDate":1806336000000,"strike":"10.50","timestamp":1790057094504,"price":0.98,"volume":360,"amount":705600,"type":"*"},{"symbol":"CSP.HK","call":true,"expireDate":1790611200000,"strike":"10.50","timestamp":1790043235547,"price":0.04,"volume":205,"amount":16400,"type":"*"}]},"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.4891,"impliedVolPercentile":0.3265},"requestUrl":"/m/hq/s/01093","defaultTab":"news","newsList":[{"id":"2669234144","title":"“药二代”密集走向台前，大多拥有海外名校背景，将如何接好“转型”这一棒？","url":"https://stock-news.laohu8.com/highlight/detail?id=2669234144","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669234144?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:16","pubTimestamp":1790079360,"startTime":"0","endTime":"0","summary":"红星资本局注意到，“药二代”们正密集走向台前。与“创一代”不同的是，他们大多拥有海外名校背景，进入核心管理层的方式也各不相同。今年以来，还有多位“药二代”走向台前。多家药企处于业务转型期二代接棒或面临考验值得一提的是，近期迎来“药二代”上台的上市公司，多数处于业务转型期。“药二代”走向前台，企业如何完成转型，仍有待时间验证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-09-22/doc-inistexc1956967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0072913022.USD","KURE","300453","BK0239","LU1152091168.USD","LU1152091754.HKD","LU1226288170.HKD","BK0102","BK0188","LU1226287529.USD","LU0315179316.USD","IE00B543WZ88.USD","HK0000165453.HKD","600380","LU1993786604.SGD","LU1226288253.USD","LU0326950275.SGD","LU0880133367.SGD","LU0140636845.USD","BK0187","BK0028","BK1521","BK0046","LU1328277881.USD","IE00BZ08YT58.USD","688166","LU1807302812.USD","000513","BK0077","300298","IE00B031HY20.USD","BK0114","LU0067412154.USD","LU1008478684.HKD","LU1226287792.SGD","BK0251","IE00BZ08YR35.GBP","LU0314109678.HKD","BK1191","IE0008368742.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","SG9999004220.SGD","IE0008369823.USD","LU1813983027.USD","LU1960683339.HKD","LU2039709279.SGD","01093","LU1226287875.USD","LU1951186391.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669514187","title":"2026民营企业500强退步榜：永辉超市排名下降57名，宁波合盛集团下降56名，石药控股下降53名","url":"https://stock-news.laohu8.com/highlight/detail?id=2669514187","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669514187?lang=zh_cn&edition=full","pubTime":"2026-09-22 19:39","pubTimestamp":1790077140,"startTime":"0","endTime":"0","summary":"专题：2026中国民营企业500强出炉！宁波合盛集团有限公司最新排名第239位，比2025年榜单下降56名，去年排名为第183名。公司营收从上期的437.59亿元下降至380.87亿元，减少56.72亿元。新浪合作大平台期货开户 安全快捷有保障新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。投资者据此操作，风险自担。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-09-22/doc-inistewz5626038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01093","BK0183","BK1191","BK1521","BK0077","LU1152091168.USD","BK0196","LU0501845795.SGD","LU1152091754.HKD","LU1328277881.USD","LU0072913022.USD","LU0326950275.SGD","LU0315179316.USD","LU0880133367.SGD","LU1807302812.USD","LU1226288170.HKD","BK1515","IE0008368742.USD","KURE","IE00BZ08YR35.GBP","LU1813983027.USD","LU2039709279.SGD","IE00BZ08YT58.USD","LU1960683339.HKD","BK0209","LU1951186391.HKD","BK0170","IE00B031HY20.USD","LU0067412154.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","IE0008369823.USD","LU1993786604.SGD","SG9999004220.SGD","LU1226287792.SGD","LU1008478684.HKD","LU0140636845.USD","IE00BZ08YS42.EUR","601933","LU1226287875.USD","LU0314109678.HKD","IE00B543WZ88.USD","LU1226288253.USD","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190565900","title":"石药集团：贝莱德增持，好仓比例升至5.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190565900","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190565900?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:24","pubTimestamp":1790069067,"startTime":"0","endTime":"0","summary":"贝莱德于2026年9月17日通过取得股份保证权益的方式增持石药集团1094.18万股股份。该笔交易属场外交易（代价性质：非现金资产），未经联交所公开市场撮合，不属二级市场直接买卖。贝莱德此次增持前持有石药集团好仓5.65亿股，占比4.91%；增持后持股量为5.76亿股，好仓比例升至5.0%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168266189","title":"石药集团：贝莱德减持，好仓比例降至4.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168266189","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168266189?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:42","pubTimestamp":1789983740,"startTime":"0","endTime":"0","summary":"贝莱德于2026年9月16日通过场外交易（代价性质：非现金资产）减持石药集团1960.45万股，每股作价未披露。此次交易因贝莱德不再持有相关股份的保证权益而触发，属场外交易，未经联交所公开市场撮合，不属二级市场直接买卖。贝莱德此次减持前持有石药集团好仓5.78亿股，占比5.02%；减持后持股量为5.58亿股，好仓比例降至4.85%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669535961","title":"花旗：医药工业发展“十五五”规划利好创新药及医疗器械 首选石药集团(01093)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2669535961","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669535961?lang=zh_cn&edition=full","pubTime":"2026-09-21 15:03","pubTimestamp":1789974221,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，花旗发布研报称，工信部等部门联合发布《医药工业发展“十五五”规划》，核心是推动中国医药工业由规模驱动增长转向创新驱动、质量导向发展，并明确提出到2030年跻身世界领先行列的目标。规划涵盖创新药、创新医疗器械、人工智能驱动药物发现，以及CDMO/CRO等技术领域，显示政策正对整条价值链作出广泛支持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498647.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GDOC","LU1152091168.USD","BK4566","LU0456827905.SGD","LU1244550494.USD","SG9999002463.SGD","RSPH","LNGR","HART","LU0067412154.USD","LU0029874061.USD","01276","LU1242518931.SGD","LU3063872942.SGD","FTXO","01801","IYF","06978","MEDX","MDEV","LGHT","06990","LU0128525689.USD","PTH","02269","159883","IE00B543WZ88.USD","LU1242518857.USD","AGNG","TFNS","LU1366192091.USD","01093","LU0455707207.USD","LU1807302812.USD","LU0561508036.HKD","LU0359201885.HKD","HK0000165453.HKD","LU1226287875.USD","BK1576","IBBQ","KURE","LU0516422440.USD","BK4588","09996","159992","LU0516422366.SGD","LU2417539215.USD","IEIH","LU0029874905.USD","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669136258","title":"港股开盘 | 恒指平开 医药股多数走强 信达生物(01801)涨近2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669136258","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669136258?lang=zh_cn&edition=full","pubTime":"2026-09-21 09:42","pubTimestamp":1789954950,"startTime":"0","endTime":"0","summary":"板块方面，医药股多数走强，存储及半导体股开盘活跃;黄金股小幅走弱，中资券商股多数下跌，科网股涨跌不一。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260921/20260921094251_54354.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260921/20260921094251_54354.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0210533765.USD","LU0540923850.HKD","LU0823041008.USD","LU0326948709.USD","LU0823397103.USD","SG9999000475.SGD","LU0516423174.USD","LU0588545490.SGD","LU1655091459.SGD","LU0588545730.USD","IE00BZ08YR35.GBP","LU1769817179.HKD","LU1868837722.USD","03067","IE00B031J352.USD","LU0541502299.USD","SG9999006514.SGD","LU1242518857.USD","LU0043850808.USD","LU0359202008.SGD","LU0345776255.USD","LU1917777945.USD","LU1993786604.SGD","HTCD.SI","LU0577902611.USD","LU2265009873.SGD","LU0828238088.HKD","LU1439103000.SGD","LU0762540952.USD","LU0708995153.HKD","LU1226288097.SGD","LU0737861772.HKD","LU0244354667.USD","LU0456842615.SGD","LU1961090484.USD","LU1323998911.USD","LU0499858438.USD","LU0229945570.USD","LU0502904849.HKD","IE0009570106.USD","LU1226287792.SGD","LU0169518387.USD","LU0541501648.USD","LU2125910849.SGD","IE00B5MMRT66.SGD","LU0070217475.USD","HHImain","IE00B0JY6N72.USD","IE0001KFT4U8.USD","IE00B8HQ1Z84.USD","LU1880398471.USD","LU0048580855.USD","LU2462611646.USD","SG9999014880.SGD","LU1366334651.USD","SG9999018857.SGD","FFEM","SG9999018865.SGD","LU1691799644.USD","SG9999001093.SGD","LU0823413587.USD","513600","BK1164","LU1105468828.SGD","LU0235996351.USD","GB00BDT5M118.USD","LU0862451753.SGD","LU0320764243.SGD","LU0985320562.USD","BK1604","LU1720051017.SGD","03423","LU2152927971.USD","IE0032431581.USD","LU0651947912.USD","LU1196710864.SGD","HK0001040168.HKD","SG9999002463.SGD","LU0417516902.SGD","JEMA","LU0203345920.USD","LU0072462343.USD","IE00B0169L03.USD","LU0326950275.SGD","LU0516422440.USD","LU0197773673.USD","LU0865486749.SGD","BK1142","09088","LU2045819591.USD","LU0348805143.USD","BK1618","BKF","LU0862451837.USD","LU2488822045.USD","LU1733274473.HKD","02800","LU1769817096.USD","LU1044876610.USD","LU0149534421.HKD","LU0868486357.SGD","LU2293587155.HKD","00700","SG9999014906.USD","IE00BMPRXN33.USD","LU0173614495.USD","LU0898667661.SGD","BK1591","LU0329678337.USD","LU1282649067.USD","LU1366334578.USD","LU2362540622.SGD","LU1171460220.USD","LU1969619763.USD","LU2153591404.USD","LU2097829019.USD","LU1224444064.USD","LU1734074674.USD","SG9999015952.SGD","LU0348825331.USD","LU2476274720.SGD","07200","BK1608","LU0061477393.USD","LU2247934214.USD","LU0307460666.USD","HK0000288743.USD","LU0593848301.USD","LU1115378108.SGD","HK0001040143.USD","SG9999000459.SGD","LU0608807946.USD","LU0117841782.USD","09067","LU0051755006.USD","TCHI","LU1718418525.SGD","LU0821914370.USD","LU0588545904.SGD","BK1531","HK0000306685.HKD","LU2242644610.SGD","IE0003851619.USD","LU0052750758.USD","LU0396098781.USD","LU0762542818.HKD","LU0672654166.SGD","SG9999015986.USD","LU0831093199.SGD","LU0873338254.USD","XSOE","BK1191","LU0320764599.SGD","LU1282649141.HKD","89988","LU0675040207.SGD","LU1316542783.SGD","LU1883866441.USD","IE0008368411.USD","BK1163","KURE","EEMX","LU0261947096.USD","LU0359201612.USD","LU1807302812.USD","IE0003795394.USD","LU0650527681.SGD","03033","TCEHY","LU0080751232.USD","LU1981816686.USD","LU0196878994.USD","LU0259732245.USD","LU2279858448.HKD","LU0417516571.SGD","LU0577902454.USD","BK1516","IE00BZ08YT58.USD","IE00BQXX3F31.USD","LU0648948544.HKD","02837","LU1196710351.USD","LU0611395673.USD","LU1675838814.USD","LU1044875133.USD","SG9999014898.SGD","03419","SG9999017495.SGD","LU0107464264.USD","LU0228367735.SGD","LU0175139822.USD","LU2362541273.HKD","SGXZ99366536.SGD","AAXJ","LU0577902371.SGD","LU2226246903.HKD","IE00B0169N27.USD","HSI","LU0572939691.SGD","LU0067412154.USD","LU0348827113.USD","LU0039217434.USD","LU0630378692.HKD","LU1770034418.SGD","LU1188198961.HKD","LU1102505762.USD","LU0499858602.USD","LU1048596156.SGD","BK1526","LU0449515922.USD","LU0823426308.USD","HK0000914686.HKD","LU1048484197.HKD","LU0784639295.USD","KWEB","LU0192582467.USD","688031","LU1226287875.USD","07226","LU2133065610.SGD","IE00BMPRXR70.SGD","LU2348773727.SGD","LU0700851271.USD","LU0049112450.USD","LU0819121731.USD","IE00B067MR52.USD","LU0106959298.USD","06727","LU0254981946.USD","LU2087589342.USD","LU0181495838.USD","LU2424517915.HKD","HK0000107257.USD","IE00BF5LJ272.USD","IE00BGV7N243.SGD","LU0633140727.USD","HK0000165453.HKD","LU0890818403.SGD","LU0029875118.USD","IE0032834883.USD","LU1688375341.USD","LU0163747925.USD","LU1785774172.SGD","SG9999001846.SGD","LU0315178854.USD","LU0289960550.SGD","09961","LU0345769128.USD","FDNI","LU2237443622.USD","LU2251237488.HKD","LU0315179316.USD","LU0048597586.USD","BK1517","LU0231483743.USD","IE0003895053.USD","LU0106252389.USD","LU0348816934.USD","LU0738912210.USD","SG9999003461.SGD","SG9999000327.SGD","LU2237443549.SGD","BK1609","IE00BZ08YS42.EUR","LU0117844026.USD","EMC","LU0648000940.SGD","LU0823426480.USD","LU1568876251.USD","LU0572944931.SGD","LU1831875114.USD","LDEM","LU0878004406.USD","LU0588546209.SGD","LU0819123356.HKD","SG9999007991.SGD","BK1587","LU0589944569.HKD","LU1629966141.USD","LU0516422366.SGD","JADE","LU0370786039.SGD","LU0630378429.USD","LU0561508036.HKD","LU0633140560.USD","IE00B3M56506.USD","LU1051769294.HKD","BK1610","LU1880383440.USD","LU1725190679.HKD","LU1951186391.HKD","BK1095","SG9999001069.SGD","LU1880398554.USD","03115","LU0414403682.SGD","LU2362541513.USD","MCHmain","HK0000352291.HKD","LU0140636845.USD","LU1810669033.SGD","LU0972618739.USD","GAMR","IE00B031HY20.USD","LU0762541174.USD","LU1242518931.SGD","LU0228659784.USD","IE0008368304.USD","LU2237443382.USD","LU0417516738.SGD","LU1282649810.SGD","03417","LU0463099449.HKD","LU1282648689.USD","LU0823397285.USD","LU0594300179.USD","IE00BQXX3D17.EUR","LU0048575426.USD","LU0477156797.USD","LU0214875030.USD","03037","LU0572940350.SGD","HK0000151867.HKD","LU0708995583.HKD","SG9999015978.USD","IE00B543WZ88.USD","LU0149721374.USD","LU1251922891.USD","LU0320764755.SGD","03088","BK1583","HBBD.SI","LU0431992006.USD","SG9999002828.SGD","LU1504937902.USD","LU0130518102.USD","LU2008162690.USD","LU0210527791.USD","SGXZ62798434.SGD","07500","BK1109","BK1584","LU2023250504.SGD","LU0823040885.USD","LU0287142896.SGD","SOCL","IE0008368742.USD","LU0531971595.HKD","LU0828237510.HKD","LU1046422090.SGD","LU3227948356.SGD","HK0000288784.HKD","LU0188438112.USD","LU1328615791.USD","LU1439102457.SGD","01801","IE00B031HW06.USD","LU1733274390.USD","LU0882747503.HKD","LU2237443465.HKD","LU0164865239.USD","LU0640798160.USD","LU1328277881.USD","LU2051468812.USD","IE00BQXX3C00.GBP","LU2237443895.HKD","82800","07300","LU0878005551.USD","LU1794554557.SGD","07552","LU1023057109.AUD","SGXZ86797644.SGD","LU0143863784.USD","LU0348783662.USD","LU0211331839.USD","LU0127658192.USD","LU0456827905.SGD","LU0106259558.USD","LU2097828714.EUR","LU0979878070.USD","HK0000306701.USD","SG9999000418.SGD","LU2476274308.USD","LU1201861165.SGD","SG9999006597.SGD","LU1548497426.USD","HSTECH","LU0605514214.HKD","IE00B29SXG58.USD","LU2257852520.SGD","SGXZ31699556.SGD","EMCS","LU0096374516.USD","LU0348735423.USD","CXSE","LU1226288253.USD","LU1152091168.USD","LU0314109678.HKD","LU1064131003.USD","LU0345769631.USD","LU1044874839.SGD","BK1575","LU0607220059.USD","09115","LU1720050803.USD","LU0049853897.USD","LU0594300419.USD","SG9999002562.SGD","LU2097828805.USD","LU0251144936.SGD","LU0211977185.USD","LU0501845795.SGD","LU2399975544.HKD","LU1211504680.USD","LU0328353924.USD","BK1515","LU1956131251.USD","HK0000352382.USD","LU2449936058.SGD","SGXZ51526630.SGD","LU1152091754.HKD","IE00B8L5B284.USD","LU0642271901.SGD","LU1008478684.HKD","BABA","LU0143863198.USD","LU0269904917.USD","LU0608807433.USD","09903","BK1501","LU0251143458.SGD","SG9999011746.SGD","LU0456846285.SGD","LU2177674079.SGD","LU0871576103.HKD","LU0348723411.USD","02833","LU1226287529.USD","LU0359201885.HKD","LU0203347892.USD","LU0577902298.EUR","LU0516423091.SGD","SG9999001226.SGD","BK1249","LU1568876335.HKD","LU1102505929.USD","LU2039709279.SGD","LU0293314216.USD","LU0047713382.USD","LU1642822792.SGD","HK0000320223.HKD","LU0531970944.HKD","LU0886674414.USD","LU1282651121.HKD","HK0000320264.USD","LU2251237306.USD","LU1196710195.USD","LU0791591158.USD","LU0918141705.HKD","LU0130103400.USD","SG9999001689.USD","LU1515016050.SGD","LU0197773160.USD","LU0165289439.USD","LU0164880469.USD","LU2778985437.USD","LU1224709979.USD","SG9999014674.SGD","IE0031814852.USD","LU0488056044.USD","LU0348784397.USD","ODDS","LU2328871848.SGD","LU2357305700.SGD","LU1206782309.USD","LU0577902538.SGD","LU1282651048.USD","LU1481107354.HKD","SG9999014914.USD","83115","LU0831103253.SGD","LU0054450605.USD","LU0791590937.USD","LU0823039010.USD","LU2097828631.EUR","LU2294711473.HKD","LU0128522744.USD","SGXZ90724238.SGD","BIDD","LU0384037296.USD","BK1502","LU1814569148.SGD","03032","LU2498475776.HKD","SG9999004220.SGD","LU0345775950.USD","LU1808992512.USD","LU1868837565.USD","HK0000914660.USD","LU2106854487.HKD","BK1521","LU0634319403.HKD","LU1804176565.USD","LU0469268626.HKD","LU0543330566.HKD","LU0918141887.USD","LU0128522157.USD","LU0543330483.HKD","LU0164872284.USD","LU1303224171.USD","LU0786609619.USD","BK1588","LU0132412106.USD","LU1226288170.HKD","LU0261950470.USD","BK1161","LU1719994722.HKD","LU0329678170.USD","SG9999013353.USD","LU0261950983.USD","LU1880383366.USD","LU0516422952.EUR","LU0054237671.USD","HK0000286598.CNH","LU0455707207.USD","LU0048388663.USD","LU0828237940.HKD","LU1813983027.USD","LU0348814723.USD","IE00B97KM107.HKD","LU1960683339.HKD","LU2125910500.SGD","SG9999001903.USD","IE00BPRC5H50.USD","LU0823413660.USD","IE0034224299.USD","ALBmain","LU0880133367.SGD","LU0683595622.HKD","LU0509642566.USD","LU0823038988.USD","LU0029874905.USD","TCOM","LU0327786744.USD","LU0856984785.SGD","LU1974910355.USD","01093","LU0210526637.USD","SGXZ81514606.USD","LU2097828474.EUR","TCHmain","LU0441854154.USD","LU2148510915.USD","LU0084288322.USD","LU0797268264.HKD","ESPO","LU1720051108.HKD","09988","LU0449509016.USD","LU0348783233.USD","SG9999015945.SGD","BK1586","LU2317271919.USD","BK1615","LU0651946864.USD","LU1048588211.SGD","BK1589","LU0264606111.USD","LU0072913022.USD","LU1868838027.USD","LU2279701549.SGD","IE0008369823.USD","LU1770036033.HKD","LU0348788117.USD","LU0737861699.HKD","LU3063872942.SGD","SG9999001051.SGD","LU1064130708.USD","LU1235295612.USD","LU1051768304.USD","LU0011963245.USD","LU2237443978.SGD","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668188139","title":"石药集团：老牌仿创药企的资本与业务重构","url":"https://stock-news.laohu8.com/highlight/detail?id=2668188139","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668188139?lang=zh_cn&edition=full","pubTime":"2026-09-20 14:11","pubTimestamp":1789884696,"startTime":"0","endTime":"0","summary":"石药集团的关联方石药控股持有另一家A股公司石药景峰控制权，后者主营中成药、特色仿注射剂，与石药集团的业务分隔开来。基本面：2026上半年盈利弹性主要来自一次性BD，内生成药业务改善具备边界港股上市的石药集团业务划分为三大板块：传统成药、原料药业务构成集团稳定现金牛，创新药板块则提供增长引擎。石药已在8月12日收到3000万美元的首付款。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789439775759723038","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0326950275.SGD","BK1521","BK1191","IE00BZ08YR35.GBP","IE0008369823.USD","LU1226287875.USD","LU1226287529.USD","BK1515","LU1813983027.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","IE00B031HY20.USD","LU0072913022.USD","LU1328277881.USD","LU0880133367.SGD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU1152091168.USD","LU1993786604.SGD","LU0067412154.USD","LU0314109678.HKD","LU0315179316.USD","LU0501845795.SGD","LU1226287792.SGD","IE00B543WZ88.USD","KURE","01093","LU1807302812.USD","SG9999004220.SGD","LU0140636845.USD","LU1008478684.HKD","LU1226288170.HKD","LU1152091754.HKD","IE0008368742.USD","LU1951186391.HKD","LU1960683339.HKD","LU1226288253.USD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110360061","title":"石药集团2026年上半年营收185.94亿元，经调整净利润61.64亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110360061","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110360061?lang=zh_cn&edition=full","pubTime":"2026-09-17 18:06","pubTimestamp":1789639609,"startTime":"0","endTime":"0","summary":"石药集团发布2026年中期报告，期内公司实现营收185.94亿元，同比增长40.1%。经调整后股东应占净利润61.64亿元，较上年同期的23.20亿元增长165.8%，毛利率从上年同期的65.6%提升至76.2%，主要受成药业务收入占比增加带动。本期公司经营活动产生的现金流入108.90亿元，而上年同期为31.87亿元。功能食品及其他业务实现收入8.73亿元，同比减少8.2%。公司对外授权收入表现亮眼，当期实现5.89亿元，已成为第二增长曲线的重要推动因素。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团2026年上半年营收185.94亿元，经调整净利润61.64亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168131000","title":"石药集团(01093)SYH2069注射液治疗成人2型糖尿病II期试验在中国首个研究中心启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1168131000","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168131000?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:40","pubTimestamp":1789555234,"startTime":"0","endTime":"0","summary":"2026年9月16日，石药集团有限公司发布自愿公告称，其研发的SYH2069注射液用于治疗成人2型糖尿病的II期临床试验已在中国首个研究中心正式启动。临床前研究显示，SYH2069具有良好的靶点活性和可控的安全性特征。本次II期试验为多中心、随机、双盲、安慰剂及阳性对照、平行分组设计，旨在评估不同给药方案下SYH2069在成人2型糖尿病患者中的有效性与安全性，当前受试者的招募与筛选工作正在推进。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607863","title":"石药集团(01093.HK)：SYH2069注射液用于治疗成人2型糖尿病的II期临床试验在中国首个研究中心正式启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607863","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667607863?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:39","pubTimestamp":1789555160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0140636845.USD","LU1807302812.USD","BK1521","SG9999004220.SGD","LU0501845795.SGD","LU0880133367.SGD","LU1226287792.SGD","LU1328277881.USD","LU1226288253.USD","IE0008369823.USD","IE00B5MMRT66.SGD","LU1993786604.SGD","LU1152091168.USD","IE00B031HY20.USD","IE0008368742.USD","LU1951186391.HKD","KURE","LU1226287875.USD","LU1226288170.HKD","LU2039709279.SGD","LU1960683339.HKD","LU0326950275.SGD","BK1515","IE00B543WZ88.USD","LU1226287529.USD","LU0072913022.USD","LU1152091754.HKD","HK0000165453.HKD","LU0315179316.USD","01093","LU1813983027.USD","LU1008478684.HKD","LU0314109678.HKD","BK1191","IE00BZ08YS42.EUR","LU0067412154.USD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667417246","title":"【投融资动态】达石药业D+轮融资，投资方为维度资本、贵阳创投等","url":"https://stock-news.laohu8.com/highlight/detail?id=2667417246","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667417246?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:25","pubTimestamp":1789471513,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP于9月9日公布的信息整理，达石药业（广东）有限公司D+轮融资，融资额未披露，参与投资的机构包括维度资本，贵阳创投，名信投资。达石药业是一家创新型抗体药物研发商，专注于创新型生物技术药物研发，主要聚焦于肿瘤治疗领域内的抗体药物，目前已经有两个药物分子进入临床前研究。公司已逐步形成从早期药品研发、CMC、临床前研究到临床试验等各个环节有着闭环能力的顶尖新药研发企业，研发及产业化将“孤儿药”潜力或明显竞争优势的抗体药物尽速推向临床应用、造福病患。数据来源：天眼查APP以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500032559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0314109678.HKD","IE00BZ08YS42.EUR","LU1328277881.USD","LU1226287875.USD","KURE","IE00BZ08YR35.GBP","LU0140636845.USD","IE00B543WZ88.USD","BK1515","LU1226288170.HKD","BK1521","BK1191","LU1951186391.HKD","LU1813983027.USD","IE0008368742.USD","LU1807302812.USD","LU0880133367.SGD","IE0008369823.USD","SG9999004220.SGD","HK0000165453.HKD","LU1152091168.USD","LU0326950275.SGD","IE00B5MMRT66.SGD","LU0072913022.USD","LU0067412154.USD","LU1993786604.SGD","LU2039709279.SGD","LU0501845795.SGD","LU1226287792.SGD","LU1008478684.HKD","LU1226288253.USD","01093","LU1226287529.USD","LU1960683339.HKD","IE00BZ08YT58.USD","LU0315179316.USD","IE00B031HY20.USD","LU1152091754.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101952267","title":"石药集团SYS 6010被纳入国家药监局突破性治疗品种清单","url":"https://stock-news.laohu8.com/highlight/detail?id=1101952267","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101952267?lang=zh_cn&edition=full","pubTime":"2026-09-15 18:11","pubTimestamp":1789467118,"startTime":"0","endTime":"0","summary":"2026年9月15日，石药集团有限公司（01093.HK）发布自愿公告称，公司自主研发的抗体偶联药物（ADC）SYS 6010已被国家药品监督管理局纳入突破性治疗品种名单，拟定适应症为既往接受免疫治疗及含铂化疗失败的复发或转移性驱动基因阴性非鳞状非小细胞肺癌（NSCLC）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691412","title":"智通港股早知道 | 国产创新药WCLC数据密集兑现 投行看好中国CRO/CDMO复苏明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691412","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667691412?lang=zh_cn&edition=full","pubTime":"2026-09-15 07:29","pubTimestamp":1789428595,"startTime":"0","endTime":"0","summary":"WCLC临床数据密集兑现，国内外投行相继看好中国CRO/CDMO复苏明确9月12日至15日，2026年世界肺癌大会在韩国首尔举行，多项国产创新药临床数据集中亮相，中国新药入选口头报告19项、小型口头报告45项，双双刷新历史纪录，肺癌领域ADC与双抗数据成为焦点。经初步测算，本次交易完成后，一汽股份将成为公司第二大和具有战略影响力的股东;本次交易预计构成重大资产重组及关联交易，不构成公司实际控制人变更，不构成重组上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU0140636845.USD","LU1226287792.SGD","BK1183","LNGR","IE00BZ08YT58.USD","LU1008478684.HKD","SG9999004220.SGD","02238","01911","LU0314109678.HKD","BK4585","IE00B5MMRT66.SGD","KCAI","159992","LU1813983027.USD","BK1147","LU2039709279.SGD","MEDX","BK1191","IBBQ","LU1152091754.HKD","LU0501845795.SGD","KURE","BK1119","LU1993786604.SGD","LU1226288170.HKD","BK1144","LU0326950275.SGD","LU1226287875.USD","LU1951186391.HKD","01093","BK1539","LU0315179316.USD","CDMO","HK0000165453.HKD","IE0008369823.USD","BK4139","LU1226287529.USD","LU1328277881.USD","BK1574","BK4588","IE0008368742.USD","IE00B543WZ88.USD","VXUS","02889","LU1960683339.HKD","06871","06978","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667269654","title":"石药集团(01093.HK)：SYS 6010联合恩朗苏拜单抗用于治疗未经系统性治疗的驱动基因阴性晚期NSCLC的I / II期临床研究数据于2026年世界肺癌大会(WCLC)上以口头报告形式公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2667269654","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667269654?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:34","pubTimestamp":1789378468,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0880133367.SGD","LU1226288253.USD","01093","LU1152091168.USD","LU2039709279.SGD","HK0000165453.HKD","LU0315179316.USD","BK1191","IE00BZ08YS42.EUR","LU1226287792.SGD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1008478684.HKD","BK1521","LU1951186391.HKD","LU1993786604.SGD","LU1813983027.USD","LU1807302812.USD","BK1515","SG9999004220.SGD","IE0008369823.USD","IE0008368742.USD","LU1226288170.HKD","LU0326950275.SGD","IE00B543WZ88.USD","LU1226287529.USD","LU0072913022.USD","LU0501845795.SGD","LU0067412154.USD","LU1328277881.USD","KURE","LU0314109678.HKD","LU1152091754.HKD","IE00BZ08YT58.USD","LU1960683339.HKD","LU0140636845.USD","IE00B5MMRT66.SGD","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666510786","title":"港股异动 | 创新药概念股持续调整 海外利率预期反复 2026国谈收官进入结果等待期","url":"https://stock-news.laohu8.com/highlight/detail?id=2666510786","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666510786?lang=zh_cn&edition=full","pubTime":"2026-09-11 11:08","pubTimestamp":1789096112,"startTime":"0","endTime":"0","summary":"消息面上，2026国谈现场谈判和价格协商收官，正式进入结果等待期。新版国家基本医保药品目录与商保创新药目录预计11月正式公布，2027年1月1日起统一执行。此外，能源供给风险急剧升温，10年期美债收益率攀升至近三年高位，市场定价美联储下周加息25BP的概率已升至约70%。分析人士指出，近期创新药板块的调整，主要受到海外利率预期反复、油价上行推升通胀担忧、临床风险事件扰动及资金风格轮动等因素影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1813983027.USD","09995","MEDX","159992","LU2488822045.USD","IE00BZ08YT58.USD","01801","LNGR","LU0067412154.USD","LU2242644610.SGD","MCRO","LU1831875114.USD","IBBQ","LU1188198961.HKD","WRTH","LU0149534421.HKD","IE0008368742.USD","IE00BZ08YS42.EUR","KCAI","LU0455707207.USD","LU1226288170.HKD","LU1807302812.USD","LU1008478684.HKD","LU1960683339.HKD","LU2328871848.SGD","BK1191","LU0326950275.SGD","LU2097828805.USD","LU2097828474.EUR","KURE","BK1161","LU0501845795.SGD","LU0072913022.USD","LU1328277881.USD","PEVC","VXUS","BK1589","LU1226287875.USD","LU0244354667.USD","01093","06978","LU1226287792.SGD","02157","LU0880133367.SGD","IE00B5MMRT66.SGD","LU2097828557.USD","BK4585","IE0008369823.USD","LU1969619763.USD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170631576","title":"全球股市综述：市场快讯","url":"https://stock-news.laohu8.com/highlight/detail?id=1170631576","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170631576?lang=zh_cn&edition=full","pubTime":"2026-09-10 15:28","pubTimestamp":1789025335,"startTime":"0","endTime":"0","summary":"分析师称，在出席巴克莱全球必需消费品大会并听取首席执行官Fernando Fernandez及印度斯坦联合利华首席执行官Priya Nair的发言后，联合利华或将成为仅次于欧莱雅的增速最快的必需消费品企业。野村将目标价从18,500日圆上调至20,000日圆，维持买入评级。该股上涨2.4%，报15,670日圆。星展恢复对该股的覆盖，给予买入评级，目标价13.70港元。该公司表示，与国内市场不同，昆士兰人口持续增长，而长期住房供应短缺已成为严峻社会问题。该股下跌0.4%，报31.60港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0197773673.USD","LU2039709279.SGD","SG9999007991.SGD","SG9999014484.SGD","IE0008368742.USD","LU0229494975.USD","SG9999013478.USD","SG9999010078.USD","LU0488056044.USD","LU0197773160.USD","LU0955648018.USD","BK4585","BK1534","LU1839390173.USD","LU1211504680.USD","SG9999016042.SGD","LU0345775950.USD","SG9999002620.SGD","SG9999000459.SGD","LU0865486749.SGD","LU0557290698.USD","SG9999001127.SGD","LU0588545904.SGD","LU0594300179.USD","LU0819121731.USD","IE00BHRH8D16.HKD","LU0594300419.USD","LU0955623706.USD","LU0205439572.USD","HK0000165453.HKD","LU1634259391.SGD","SG9999002604.SGD","LU0048597586.USD","SG9999009997.SGD","IE0031814969.USD","LU0165289439.USD","LU1316543674.SGD","LU3227948356.SGD","SG9999014302.SGD","LU0878004406.USD","LU0329678170.USD","LU0648948544.HKD","SG9999002562.SGD","BK1515","LU2506952097.USD","LU0689626769.HKD","LU0211331839.USD","SG9999003925.USD","00688","LU0315178854.USD","LU1960683339.HKD","LU0823413587.USD","LU0096374516.USD","BK4592","SG9999013486.USD","SGXZ70427877.SGD","IE0003895053.USD","LU1282649141.HKD","LU1497733631.SGD","SG9999004220.SGD","CAOVY","SGXZ43160589.SGD","LU0762540952.USD","LU1130305938.SGD","SG9999004360.SGD","LU1224709979.USD","LU0823397285.USD","LU0315179316.USD","LU1956131251.USD","SGXZ27511609.SGD","LU0878005551.USD","LU0441851309.USD","LU0630378692.HKD","SG9999001226.SGD","SG9999000475.SGD","LU1282649067.USD","SG9999002679.SGD","SG9999006266.SGD","LU0882747503.HKD","LU2226123227.USD","LU0823417653.USD","LU0320764755.SGD","LU2226123490.SGD","LU0011963245.USD","LU0048573645.USD","LU0630378429.USD","IE00BKZH1Z71.USD","LU0672654166.SGD","LU0737861772.HKD","LU0384037296.USD","03121","BK6523","LU0532188223.SGD","LU0823397103.USD","LU1226288170.HKD","BK1555","LU1282649810.SGD","SG9999001846.SGD","IE00B543WZ88.USD","SG9999002406.SGD","SG9999009443.AUD","SGXZ16066938.SGD","SG9999005177.SGD","BK4588","LU1226287875.USD","SG9999011175.SGD","LU0823039010.USD","LU0577902611.USD","LU0314109678.HKD","LU0326948709.USD","BK1601","IE0008369823.USD","LU0501845795.SGD","LU0856984785.SGD","IE00BHRH8C09.USD","LU2237957902.USD","LU0072913022.USD","LU0880133367.SGD","01997","IE00BVYPNQ40.USD","LU0173614495.USD","LU1504937902.USD","LU1522347837.USD","LU0650527681.SGD","IE00BG0RBZ43.SGD","LU0577902371.SGD","LU1152091168.USD","LU0084288322.USD","SG9999002414.USD","LU0543330483.HKD","LU0831103253.SGD","LU1770036033.HKD","LU0971096721.USD","LU2237957811.SGD","SGXZ51708014.SGD","LU1226287529.USD","SG9999001135.SGD","LU0261947096.USD","LU2506952170.USD","01093","LU1363072403.SGD","BK1240","LU0287142896.SGD","LU0261945553.USD","LU0823413660.USD","LU1008478684.HKD","BK1521","LU0831093199.SGD","LU0886674414.USD","LU0235996351.USD","LU0588545490.SGD","LU1813983027.USD","IE00BZ08YT58.USD","LU0210637038.USD","LU1226288253.USD","LU1807302812.USD","LU2506951875.HKD","LU0140636845.USD","UL","IE00BGHQDM52.EUR","SG9999008742.SGD","UN","LU0823038988.USD","LU0188438112.USD","LU0251144936.SGD","SGXZ91733576.SGD","BK6112","LU0251143029.SGD","LU0043850808.USD","SG9999010052.SGD","LU0345776255.USD","BK1258","IE00BVYPNP33.GBP","LU0169518387.USD","SG9999000343.SGD","SG9999001903.USD","SG9999003826.SGD","LU1152091754.HKD","D05.SI","LU2152927971.USD","LU2257852520.SGD","LU0588545730.USD","LU0124676726.USD","LU0067412154.USD","SG9999013353.USD","LU0873338254.USD","BK1191","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU0823417737.USD","LU0192582467.USD","LU1328277881.USD","IE00B5MMRT66.SGD","LU1497734951.SGD","LU1951186391.HKD","ULVR.UK","LU2506951958.HKD","LU0128522157.USD","LU0326950275.SGD","BK6516","LU0737861269.HKD","SGXZ58947870.SGD","KURE","LU0577902298.EUR","SGXZ24219693.SGD","LU0737861699.HKD","LU0605514214.HKD","LU0061477393.USD","BK4183","LU1993786604.SGD","LU0577902454.USD","LU0441854154.USD","LU1328615791.USD","LU0955669360.SGD","LU1497733557.USD","IE00BZ08YS42.EUR","LU0029875118.USD","SG9999003800.SGD","SG9999014492.USD","LU0329678337.USD","LU0675040207.SGD","SG9999013460.SGD","BK1229","LU0898667661.SGD","LU1634259557.SGD","LU1226287792.SGD","LU2238330802.EUR","LU0950375773.USD","LU0577902538.SGD","LU0819123356.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2666568197","title":"大行评级丨里昂：重申石药“高确信跑赢大市”评级，股价急挫创造入市机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2666568197","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666568197?lang=zh_cn&edition=full","pubTime":"2026-09-10 14:47","pubTimestamp":1789022823,"startTime":"0","endTime":"0","summary":"石药集团与阿斯利康合作开发口服Lp项目YS2302018，目前正处于第一期临床阶段。该行指，市场亦流传关于石药集团旗下恩必普在国家医保目录续期结果不利的消息。就此，该行已向公司确认，价格调整幅度可控。里昂认为，HORIZON作为首个Lp结果研究的失败，并不会立即推翻Lp预测。石药集团股价急挫带来具吸引力的入市机会，重申对其“高确信跑赢大市”评级，目标价19港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260910/32365939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666550223","title":"港股异动 | 石药集团(01093)跌超4% Lp(a)HORIZON研究受阻或对包括公司在内的参与者构成压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2666550223","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666550223?lang=zh_cn&edition=full","pubTime":"2026-09-10 14:13","pubTimestamp":1789020819,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，石药集团跌超4%，截至发稿，跌2.69%，报8.855港元，成交额9.38亿港元。里昂发布研报称，诺华行政总裁最新对LpHORIZON研究的评论，可能将研究失败归因于晚期降低Lp相较于基因的终身Lp暴露，所带来的心血管益处有限，这将对包括石药集团在内的中国内地Lp参与者构成压力。里昂认为，HORIZON作为首个Lp结果研究的失败，并不会立即推翻Lp预测。另一方面，石药集团股价急挫带来具吸引力的入市机会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494328.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0501845795.SGD","IE00BZ08YS42.EUR","SG9999004220.SGD","IE0008368742.USD","LU1226288253.USD","IE00BZ08YR35.GBP","LU0314109678.HKD","KURE","LU1226288170.HKD","VXUS","LU1807302812.USD","BK1515","LU1993786604.SGD","LU1226287529.USD","BK4585","IE0008369823.USD","LU1960683339.HKD","LU2039709279.SGD","LU1008478684.HKD","BK4588","LU1951186391.HKD","LU0315179316.USD","IE00B5MMRT66.SGD","LU1152091168.USD","01093","HK0000165453.HKD","LU1813983027.USD","IE00B031HY20.USD","IE00B543WZ88.USD","LU0067412154.USD","BK1191","LU1226287792.SGD","LU0072913022.USD","LU1226287875.USD","BK1521","IE00BZ08YT58.USD","LU0880133367.SGD","LU1328277881.USD","KCAI","LU0326950275.SGD","LU0140636845.USD","LU1152091754.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666550551","title":"里昂：重申石药集团(01093.HK)“高确信跑赢大市”评级 目标价19港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666550551","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666550551?lang=zh_cn&edition=full","pubTime":"2026-09-10 14:00","pubTimestamp":1789020018,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1226287875.USD","KURE","LU1226287529.USD","SG9999004220.SGD","IE00B031HY20.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1226287792.SGD","BK1521","LU1960683339.HKD","LU1951186391.HKD","LU0067412154.USD","LU1328277881.USD","IE00B543WZ88.USD","LU1993786604.SGD","BK1515","IE0008369823.USD","LU0072913022.USD","HK0000165453.HKD","IE0008368742.USD","IE00BZ08YR35.GBP","LU1152091754.HKD","BK1191","LU0880133367.SGD","LU0326950275.SGD","01093","LU0314109678.HKD","LU0315179316.USD","LU1008478684.HKD","LU1807302812.USD","LU1226288253.USD","IE00BZ08YS42.EUR","LU1813983027.USD","IE00BZ08YT58.USD","LU0501845795.SGD","LU1226288170.HKD","LU2039709279.SGD","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191841564","title":"异动解读｜石药集团盘中下跌3.3%，医药板块整体承压延续调整","url":"https://stock-news.laohu8.com/highlight/detail?id=1191841564","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191841564?lang=zh_cn&edition=full","pubTime":"2026-09-10 10:15","pubTimestamp":1789006544,"startTime":"0","endTime":"0","summary":"9月10日，石药集团盘中下跌3.3%，报8.8港元，成交额2.19亿港元。消息面上，全球股市近日出现集体调整，欧洲主要股指开盘下跌、日韩股市连续收跌，避险情绪蔓延持续拖累港股医药板块。同行业个股普遍走弱，翰森制药跌2.18%、中国生物制药跌2.14%、恒瑞医药跌2.66%、复星医药跌4.05%、四环医药跌3.87%，板块整体承压。此外，此前汇添富基金以每股均价约9.75港元减持石药集团约3912万股，持股比例由5.27%降至4.93%，机构减持动向或对短期情绪构成压力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"石药集团盘中下跌，医药板块承压调整","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":0.1161},{"period":"1month","weight":0.0566},{"period":"3month","weight":0.43},{"period":"6month","weight":0.2166},{"period":"1year","weight":0.0141},{"period":"ytd","weight":0.1777}],"compareEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":-0.0354},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.0093},{"period":"1year","weight":-0.0477},{"period":"ytd","weight":-0.0212}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事药品的生产及销售的公司。该公司主要从事成药业务、原料产品业务、功能食品及其他业务。该公司的产品主要涵盖神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢以及其他治疗领域。该公司的产品销往国内外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.009625},{"month":2,"riseRate":0.75,"avgChangeRate":0.094313},{"month":3,"riseRate":0.46875,"avgChangeRate":0.017543},{"month":4,"riseRate":0.59375,"avgChangeRate":0.057684},{"month":5,"riseRate":0.59375,"avgChangeRate":0.042479},{"month":6,"riseRate":0.3125,"avgChangeRate":0.001853},{"month":7,"riseRate":0.393939,"avgChangeRate":0.015989},{"month":8,"riseRate":0.454545,"avgChangeRate":0.011919},{"month":9,"riseRate":0.515152,"avgChangeRate":0.001865},{"month":10,"riseRate":0.5625,"avgChangeRate":0.01001},{"month":11,"riseRate":0.46875,"avgChangeRate":0.006831},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013329}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}